Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus midazolam premedication for cognitive outcomes after coronary artery bypass graft surgery
IRCT20170429033680N7Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of dexmedetomidine and midazolam in coronary arteriosclerosis (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoint: Cognitive status before and after surgery. Started Nov 2016; status: completed.
02
Drugs
dexmedetomidinemidazolam
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on IRCT20170429033680N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170429033680N7.